33 related articles for article (PubMed ID: 21883401)
1. Serum granulysin is a marker for Th1 type immunity in pre-eclampsia.
Sakai M; Ogawa K; Shiozaki A; Yoneda S; Sasaki Y; Nagata K; Saito S
Clin Exp Immunol; 2004 Apr; 136(1):114-9. PubMed ID: 15030522
[TBL] [Abstract][Full Text] [Related]
2. Assessment of serum granulysin and cathepsin-L levels in vitiligo patients.
Yazar C; Akbayrak A; Ozmen ZC; Kuyucu YE; Sencan M; Kutlu O; Seckin HY
Rev Assoc Med Bras (1992); 2024; 70(5):e20231107. PubMed ID: 38775500
[TBL] [Abstract][Full Text] [Related]
3. Serum Granulysin as a Possible Key Marker of Vitiligo Activity and Severity.
Mustafa AI; Abdel-Halim WAE; Osman MM; Rezk SM
Indian Dermatol Online J; 2024; 15(3):431-436. PubMed ID: 38845658
[TBL] [Abstract][Full Text] [Related]
4. Immunopathogenesis of Behçet's disease.
Al-Obeidi AF; Nowatzky J
Clin Immunol; 2023 Aug; 253():109661. PubMed ID: 37295542
[TBL] [Abstract][Full Text] [Related]
5. Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.
Cavers A; Kugler MC; Ozguler Y; Al-Obeidi AF; Hatemi G; Ueberheide BM; Ucar D; Manches O; Nowatzky J
Ann Rheum Dis; 2022 Nov; 81(11):1603-1611. PubMed ID: 35922122
[TBL] [Abstract][Full Text] [Related]
6. Granulysin: a novel antimicrobial.
Kumar J; Okada S; Clayberger C; Krensky AM
Expert Opin Investig Drugs; 2001 Feb; 10(2):321-9. PubMed ID: 11178344
[TBL] [Abstract][Full Text] [Related]
7. Involvement of granulysin-producing T cells in the development of superficial microbial folliculitis.
Oono T; Morizane S; Yamasaki O; Shirafuji Y; Huh WK; Akiyama H; Iwatsuki K
Br J Dermatol; 2004 May; 150(5):904-9. PubMed ID: 15149502
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of peripheral blood granulysin-producing cytotoxic T lymphocytes in preeclampsia.
Molvarec A; Shiozaki A; Ito M; Toldi G; Stenczer B; Szarka A; Nakashima A; Vásárhelyi B; Rigó J; Saito S
J Reprod Immunol; 2011 Sep; 91(1-2):56-63. PubMed ID: 21763002
[TBL] [Abstract][Full Text] [Related]
9. NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions.
Schlapbach C; Zawodniak A; Irla N; Adam J; Hunger RE; Yerly D; Pichler WJ; Yawalkar N
Allergy; 2011 Nov; 66(11):1469-76. PubMed ID: 21819408
[TBL] [Abstract][Full Text] [Related]
10. Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.
Andersson J; Samarina A; Fink J; Rahman S; Grundström S
Infect Immun; 2007 Nov; 75(11):5210-22. PubMed ID: 17664265
[TBL] [Abstract][Full Text] [Related]
11. Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.
Clemente A; Cambra A; Munoz-Saá I; Crespí C; Pallarés L; Juan A; Matamoros N; Julià MR
Immunol Lett; 2010 Apr; 129(2):57-63. PubMed ID: 20167234
[TBL] [Abstract][Full Text] [Related]
12. Granulysin-producing cytotoxic T cells in the mucocutaneous lesions of Behçet disease: a distinct inflammatory response from erythema nodosum.
Yamasaki O; Morizane S; Aochi S; Ogawa K; Oono T; Iwatsuki K
Clin Exp Dermatol; 2011 Dec; 36(8):903-7. PubMed ID: 21883401
[TBL] [Abstract][Full Text] [Related]
13. Granulysin: The attractive side of a natural born killer.
Sparrow E; Bodman-Smith MD
Immunol Lett; 2020 Jan; 217():126-132. PubMed ID: 31726187
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
